WST EBITDA Margin
West Pharmaceutical Services · EBITDA Margin
WST EBITDA Margin
Latest reported26.17%period ending
WST TTM EBITDA Margin (19.87% → 26.17%)
TTM ebitda margin
High-resolution chart · PNG
WST ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 26.1656% | |
| 26.1955% | |
| 25.2464% | |
| 25.59% | |
| 25.6909% | |
| 25.2452% | |
| 25.7407% | |
| 25.8735% | |
| 26.5703% | |
| 27.8891% | |
| 28.6165% | |
| 27.3513% | |
| 25.9276% | |
| 27.0721% | |
| 27.9859% | |
| 29.7829% | |
| 31.1046% | |
| 31.0099% | |
| 31.0736% | |
| 30.0708% | |
| 28.4344% | |
| 26.052% | |
| 23.9799% | |
| 23.222% | |
| 22.6977% | |
| 22.2087% | |
| 21.8703% | |
| 21.8841% | |
| 22.0128% | |
| 21.1392% | |
| 20.5588% | |
| 20.1671% | |
| 20.5528% | |
| 19.8575% | |
| 20.3787% | |
| 20.2311% | |
| 19.5468% | |
| 20.8379% | |
| 20.7621% | |
| 20.5449% | |
| 17.2454% | |
| 15.9958% | |
| 15.7165% | |
| 15.663% | |
| 18.961% | |
| 20.0284% | |
| 19.326% | |
| 18.921% | |
| 18.733% | |
| 18.0041% | |
| 18.2476% | |
| 17.9558% | |
| 17.2548% | |
| 15.9519% | |
| 15.9665% | |
| 15.8026% | |
| 15.8442% | |
| 16.3947% | |
| 15.6588% | |
| 14.1944% | |
| 14.3552% | |
| 13.1864% | |
| 13.2706% | |
| 14.3673% | |
| 14.6014% | |
| 16.2408% | |
| 15.7715% | |
| 17.0092% | |
| 15.9896% | |
| 16.9942% | |
| 18.1827% | |
| 18.4882% | |
| 16.7334% | |
| 14.7019% | |
| 13.4987% | |
| 12.2603% | |
| 13.2668% | |
| 13.3003% | |
| 12.5589% | |
| 12.8606% | |
| 14.1854% | |
| 15.0563% | |
| 15.4759% | |
| 16.2048% | |
| 15.5976% | |
| 15.6413% | |
| 16.3405% | |
| 16.1792% | |
| 16.5959% | |
| 16.0316% | |
| 15.162% | |
| 13.7481% | |
| 14.2762% | |
| 14.615% | |
| 16.5356% | |
| 18.6972% | |
| 19.1784% | |
| 19.693% | |
| 16.7045% | |
| 12.6246% |